Table 4. Significantly enriched pathways for differential mean and dispersion of cortex versus cerebellum brain tissues.
GO term | Ontology | No. genes | Differential mean | Differential variability | ||
---|---|---|---|---|---|---|
NES | FDR q-value | NES | FDR q-value | |||
Pathways significant for differential mean but not differential dispersion | ||||||
Organelle Localization | BP | 23 | 1.67 | 1.28 | 0.207 | |
Positive Regulation Of Phosphate Metabolic Process | BP | 21 | 1.68 | 1.25 | 0.243 | |
Pathways significant for differential variability but not differential mean | ||||||
Cell Cell Adhesion | BP | 74 | 1.23 | 0.275 | 1.66 | |
Galactosyltransferase Activity | MF | 15 | 1.15 | 0.377 | 1.64 | |
Hemopoietic Or Lymphoid Organ Development | BP | 67 | 1.14 | 0.405 | 1.59 | |
Hemostasis | BP | 39 | 1.30 | 0.216 | 1.59 | |
Kinase Regulator Activity | MF | 42 | 1.29 | 0.222 | 1.62 | |
Protein Kinase Regulator Activity | MF | 36 | 1.30 | 0.216 | 1.65 |
Pathways are considered significant at FDR q-value <0.05 and insignificant at FDR q-value ≥0.2. Significant FDR q-values are boldfaced. The normalized enrichment score (NES) and FDR q-value for NES are shown. Positive NES indicates enrichment in the cortex, and negative NES indicates enrichment in the cerebellum.